Injectable
Tesamorelin
A growth hormone–releasing hormone (GHRH) analog used to reduce visceral fat and support healthy body composition.
- GHRH analog — stimulates the body's natural HGH
- Studied for reducing visceral adipose tissue (deep belly fat)
- Supports body composition, recovery, and metabolic health
- Subcutaneous injection, typically once daily
About the ingredient
Tesamorelin Acetate
A synthetic analog of growth hormone–releasing hormone (GHRH) that binds GHRH receptors on pituitary somatotrophs, stimulating endogenous HGH release.
Tesamorelin is a growth hormone–releasing hormone (GHRH) analog that stimulates the pituitary gland to produce and release the body's own human growth hormone (HGH). It is best known for its clinically studied ability to reduce visceral adipose tissue — the deep abdominal fat associated with metabolic and cardiovascular risk.
By increasing endogenous HGH in a natural, pulsatile pattern rather than replacing it directly, Tesamorelin supports improved body composition, recovery, and metabolic health. It is commonly used in body-composition, longevity, and hormone-optimization protocols, often alongside other peptides.
Stimulates endogenous HGH
Tesamorelin amplifies the body's natural pulsatile release of HGH rather than introducing exogenous hormone, preserving normal feedback regulation.
Visceral fat reduction
Best known clinically for its ability to reduce visceral adipose tissue — the metabolically active deep abdominal fat.
Bedtime dosing
Administered before bed to align with the body's nocturnal HGH pulse, the largest natural surge in adults.
How to take
A consistent routine matters.
Follow the specific directions from your healthcare provider. These steps are a general reference for injectable administration.
- 1
Inspect the vial — solution should be clear and free of particles before each use.
- 2
Clean the vial stopper with a fresh alcohol swab and let it air-dry.
- 3
Draw the prescribed dose using an insulin syringe; tap out any air bubbles.
- 4
Inject subcutaneously into the abdomen, thigh, or upper arm, rotating sites each dose.
- 5
Discard the used syringe immediately in an FDA-cleared sharps container.
Product Details
Available formulations
| Vial Total mg | Concentration | mL |
|---|---|---|
| 10 mg | 5 mg/mL | 2 mL |
Typical dosage & titration
Recommended titration schedule
Reference schedule only — your provider may adjust the timing or dose based on your individual response and lab work.
| Weeks | Units | MG | ML | SIG / Directions |
|---|---|---|---|---|
| 1–4 | 20 | 1 mg | 0.2 mL | Inject 20 units (1 mg) subcutaneously once daily before bedtime. |
| 5+ | 40 | 2 mg | 0.4 mL | Inject 40 units (2 mg) subcutaneously once daily before bedtime, or as directed by your provider. |
FAQ
Frequently asked questions
Provider workflow
Ready to prescribe Tesamorelin?
Submit a prescription through the Logos RX provider portal, or reach out to our pharmacy team for formulary, dosing, or patient-onboarding questions.
You may also be interested in
Related products
Tesamorelin
Provider onboarding portal